2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy

Published:2024-06 Issue:23 Volume:83 Page:2324-2405
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ommen Steve R.,Ho Carolyn Y.,Asif Irfan M.,Balaji Seshadri,Burke Michael A.,Day Sharlene M.,Dearani Joseph A.,Epps Kelly C.,Evanovich Lauren,Ferrari Victor A.,Joglar José A.,Khan Sadiya S.,Kim Jeffrey J.,Kittleson Michelle M.,Krittanawong Chayakrit,Martinez Matthew W.,Mital Seema,Naidu Srihari S.,Saberi Sara,Semsarian Christopher,Times Sabrina,Waldman Cynthia Burstein

Publisher

Elsevier BV

Reference749 articles.

1. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (US),2011

2. Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (US),2011

3. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines;Anderson;J Am Coll Cardiol,2014

4. ACCF/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines,2010

5. Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Halperin;J Am Coll Cardiol,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy;European Heart Journal;2024-09-01

2. Atrial Fibrillation in Hypertrophic Cardiomyopathy;JACC: Advances;2024-09

3. Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy;Journal of the American College of Cardiology;2024-09

4. One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy;Frontiers in Cardiovascular Medicine;2024-08-30

5. A Cautionary Tale of Hypertrophic Cardiomyopathy—From “Benign” Left Ventricular Hypertrophy to Stroke, Atrial Fibrillation, and Molecular Genetic Diagnostics: A Case Report and Review of Literature;International Journal of Molecular Sciences;2024-08-29